Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,697 | -3,906 | 2,897 | -40,448 | -32,274 |
| Depreciation Amortization | 1,064 | 764 | 455 | 2,235 | 1,702 |
| Accounts receivable | N/A | N/A | N/A | N/A | -2,698 |
| Accounts payable and accrued liabilities | -2,824 | -3,239 | -3,248 | -2,697 | -162 |
| Other Working Capital | -2,991 | -1,283 | -2,843 | -2,191 | -4,354 |
| Other Operating Activity | -7,747 | -8,144 | -8,436 | 718 | 503 |
| Operating Cash Flow | $-23,195 | $-15,808 | $-11,175 | $-42,383 | $-37,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -153 | -153 |
| Net Acquisitions | 28,120 | 28,120 | 28,120 | 4,250 | 4,250 |
| Investing Cash Flow | $28,120 | $28,120 | $28,120 | $4,097 | $4,097 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,730 | N/A | N/A | N/A | N/A |
| Debt Repayment | -22,104 | -22,104 | -22,104 | -137 | N/A |
| Common Stock Issued | 0 | 0 | 0 | 20,344 | 20,263 |
| Other Financing Activity | 0 | 0 | 0 | -58 | 21 |
| Financing Cash Flow | $2,626 | $-22,104 | $-22,104 | $20,149 | $20,284 |
| Beginning Cash Position | 19,946 | 19,946 | 19,946 | 38,083 | 38,083 |
| End Cash Position | 27,497 | 10,154 | 14,787 | 19,946 | 25,181 |
| Net Cash Flow | $7,551 | $-9,792 | $-5,159 | $-18,137 | $-12,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,195 | -15,808 | -11,175 | -42,383 | -37,283 |
| Capital Expenditure | 0 | 0 | 0 | -153 | -153 |
| Free Cash Flow | -23,195 | -15,808 | -11,175 | -42,536 | -37,436 |